Several studies have demonstrated that tumors with low levels of TS, DPD and TP gene expression are more sensitive to 5-FU, not only in advanced or recurrent colorectal cancer, but also in gastric cancer and breast cancer (22–25). The gene discussed is DPYD; the disease is colorectal cancer.